Liquid chromatographic-mass spectrometric method for quantitative determination of lisinopril in human plasma

Pharmazie

Volumn 59, Issue 1, 2004, Pages 21-24

  Tashtoush, Bassam M ^a   Alali, F Q ^a   Najib, N M ^b  

^a JORDAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Jordan)

^b International Pharmaceutical Research Center Amman   (Jordan)

Author keywords

[No Author keywords available]

Indexed keywords

ENALAPRIL; LISINOPRIL;

ACCURACY; ARTICLE; CONTROLLED STUDY; DRUG DETERMINATION; DRUG STABILITY; HUMAN; HUMAN TISSUE; ION MONITORING; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; SOLID PHASE EXTRACTION; STANDARD;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALIBRATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ENALAPRIL; FREEZING; HUMANS; LISINOPRIL; MASS SPECTROMETRY; QUALITY CONTROL; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS;

EID: 1642542365     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Bonazzi D, Gotti R, Andrisano V, Cavrini V (1997) Analysis of ACE inhibitors in pharmaceutical dosage forms by derivative UV spectroscopy and liquid chromatography (HPLC). J Pharm. Biomed Anal 16: 431-438
2. Dollery C (1999) Therapeutic Drugs, Vol. 2, (2 Ed) Churchill Levingstone, pp. L63-67.
3. El-Gindy A, Ashour A, Abdel-Fattah L. Shabana M. M. (2001) Spectrophotometric, spectrofluorimetric and LC determination of lisinopril. J Pharm Biomed Anal 25: 913-922
4. th edition. McGraw-Hill INC, New York pp. 745, 776.
5. Kocijan A, Grahek R, Kocjan D, Zupancic-Kralj L (2001) Effect of column temperature on the behavior of some angiotensin converting enzyme inhibitors during high-performance liquid chromatographic analysis. J Chromatogr B Biomed Sci Appl 755: 229-235.
6. Leis HJ, Fauler G, Rasptnig G, Windischhofer W (1998) Quantitative determination of angiotensin-converting enzyme inhibitor lisinopril in human plasma by stable isotope dilution gas chromatography/negative ion chemical ionization mass spectrometry. Rapid Commun Mass Spectrom 12: 1591-1594
7. Leis HJ, Fauler G, Rasptnig G, Windischhofer W (1999) An improved method for the measurement of angiotensin-converting enzyme inhibitor lisinopril in human plasma by stable isotope dilution gas chromatography/negative ion chemical ionization mass spectrometry. Rapid Commun Mass Spectrom. 13: 650-653
8. nd edition, Pharmaceutical press, p. 799.
9. Pitt B, Nicklas JM (1994) Heart failure: clinical implications of recent trials. Contemp Intern Med 6: 47-55.
10. Sun Y, Mendelsohn F A (1991) Angiotensin converting enzyme inhibition in heart, kidney, and serum studied ex vivo after administration of zofenopril, captopril, and lisinopril. J Cardiovasc Pharmacol 18: 478-486.
11. Wong YC, Charles BG (1995) Determination of the angiotensin-converting enzyme inhibitor lisinopril in urine using solid extraction and reversedphase high-performance liquid chromatography. J Chromatgr B Biomed Appl 673: 306-310.
12. Worland PJ, Jarrott B (1986) Radioimmunoassay for quantitative of lisinopril and enalaprilat. J Pharm Sci 75: 512-516.
13. Yuan AS, Gilbert JD (1996) Time-resolved fluoroimmunoassay for the determination of lisinopril and enalprilat in human plasma. J Pharm Biomed Anal 14: 773-781.